Allakos Inc
$0.33
(as of May 1, 9:30 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Allakos Inc
Stock Price
$0.33
Ticker Symbol
ALLK
Exchange
NASDAQ
Industry Information for Allakos Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Allakos Inc
Allakos Inc., a clinical stage biotechnology company, engages in the development of therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Fundamentals for Allakos Inc
Market Capitalization
$29,462,902
EBITDA
$-115,003,664
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-1.30
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
90,377,000
Percent Owned by Insiders
2.04%
Percent Owned by Institutions
100.90%
52-Week High
52-Week Low
Technical Indicators for Allakos Inc
Analyst Ratings for Allakos Inc
Strong Buy
0
Buy
0
Hold
5
Sell
0
Strong Sell
0
News About Allakos Inc
Apr 2, 2025, 10:23 AM EST
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
See more.
Apr 2, 2025, 8:00 AM EST
SAN CARLOS, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. See more.
Mar 12, 2025, 4:02 PM EST
SAN CARLOS, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the fourth quarter ended December 31, 2024.
See more.
Feb 11, 2025, 11:30 AM EST
SOUTH SAN FRANCISCO, Calif., Feb. See more.